Relative dose intensity (RDI) related to international prognostic index (IPI) in chemosensitive elderly patients with aggressive non-hodgkin lymphoma (NHL). No benefits on disease-free survival (DFS) in high-risk patients

✍ Scribed by Gomez, H.; Medina, R.; Casanova, L.; Valdivia, S.; Rodriguez, W.; Carracedo, C.; Santillana, S.; Leon, J.; Flores, C.; Vallejos, C.

• Book ID: 123280172
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 163 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(99)81761-4